Related Experiment Video
Updated: Dec 23, 2025

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
Diffuse large B-cell lymphoma of the rectum in a patient with Crohn's disease
Adam Joseph Hardy1, Ionica Stoica2, David Edward Kearney3
1Department of Paediatric Surgery, Our Lady's Children's Hospital, Dublin, Ireland hardyadams01@gmail.com.
Insights
A patient with Crohn's disease developed advanced rectal cancer invading the bladder. Despite treatment and surgery, he later succumbed to complications including sepsis and kidney injury.
Area of Science:
- Oncology
- Urology
- Gastroenterology
Background:
- A 62-year-old male with a history of Crohn's disease, subtotal colectomy, and ileostomy presented with gastrointestinal and urinary symptoms.
- The patient had previously undergone biological therapy for Crohn's disease, complicating the diagnostic and treatment pathway.
Observation:
- Initial symptoms included diarrhea and dysuria, leading to diagnoses of urinary tract infection and acute kidney injury.
- Imaging revealed a large pelvic mass compressing ureters, later identified as stage IV non-Hodgkin's diffuse large B-cell lymphoma invading the bladder.
Findings:
- The patient received chemotherapy (rituximab, cyclophosphamide, hydroxydaunomycin, oncovin, prednisolone) followed by pelvic exenteration (cystoprostatectomy, rectal stump excision, ileal conduit).
- Histology confirmed no residual malignancy post-surgery.
- One year later, the patient experienced aspiration pneumonia, urosepsis, and acute kidney injury, ultimately leading to multiorgan failure and death.
Implications:
- This case highlights the complex management of advanced pelvic malignancies in patients with pre-existing gastrointestinal conditions.
- It underscores the potential for severe complications, including sepsis and renal failure, even after successful cancer treatment and surgery.
- The case emphasizes the critical role of multidisciplinary care in managing such challenging oncological and urological emergencies.
Abstract:
A 62-year-old man presented to our institute with diarrhoea and dysuria on a background of subtotal colectomy and end ileostomy and biological therapy for Crohn's disease. He was diagnosed with urinary tract infection and acute kidney injury (AKI). Renal ultrasound suggested left hydronephrosis, with renal protocol computed tomography (CT) showing a large pelvic mass. Magnetic resonance imaging (MRI) of the pelvis demonstrated a rectal tumour invading the bladder and compressing both ureters. He underwent cystoscopy, flexible sigmoidoscopy and positron emission tomography-CT and was diagnosed with stage IV non-Hodgkin's diffuse large B-cell lymphoma. He was treated primarily with rituximab, cyclophosphamide, hydroxydaunomycin, oncovin and prednisolone chemotherapy regimen. He had ongoing urosepsis before admission for pelvic exenteration. He underwent cystoprostatectomy, excision of rectal stump and formation of ileal conduit. Histology showed no signs of residual malignancy. One year later, the patient was admitted to the intensive care unit with aspiration pneumonia, urosepsis and AKI. Despite maximal therapy, he developed multiorgan failure and passed away.
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...

